An engineered glioblastoma model yields macrophage-secreted drivers of invasion
Open Access
- 22 August 2025
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (16)
Abstract
While the accumulation of tumor-associated macrophages (TAMs) in glioblastoma (GBM) has been well documented, targeting TAMs has thus far yielded limited clinical success in slowing GBM progression due, in part, to an incomplete understanding of TAM function. Using an engineered 3D hydrogel–based model of the brain tumor microenvironment (TME), we show that M2-polarized macrophages stimulate transcriptional and phenotypic changes in GBM stem cells (GSCs) closely associated with the highly aggressive and invasive mesenchymal subtype. By combining proteomics with GBM patient single-cell transcriptomics, we identify multiple TAM-secreted proteins with putative proinvasive functions and validate TGF-β induced (TGFBI, also known as BIGH3) as a targetable TAM-secreted tumorigenic factor. Our work highlights the utility of coupling multiomics analyses with engineered TME models to investigate TAM–cancer cell crosstalk and offers insights into TAM function to guide TAM-targeting therapies.Keywords
All Related Versions
Funding Information
- National Science Foundation (DGE 1752814)
- National Institutes of Health (R01CA260443,R01CA227136)
- National Science Foundation (DGE 2146752)
- National Institutes of Health (P30-CA008748)
This publication has 92 references indexed in Scilit:
- Gene Set Knowledge Discovery with EnrichrCurrent Protocols, 2021
- Biomaterials and 3D Bioprinting Strategies to Model Glioblastoma and the Blood–Brain BarrierAdvanced Materials, 2020
- Time series assessment of the effects of hypoxic stress on glioma tumorsphere development within engineered microscale nichesBiomaterials, 2019
- Transforming growth factor beta induced (TGFBI) is a potential signature gene for mesenchymal subtype high-grade gliomaJournal of Neuro-Oncology, 2018
- Crosstalk between M2 macrophages and glioma stem cellsCellular Oncology, 2017
- Comparative proteomics of glioma stem cells and differentiated tumor cells identifies S100A9 as a potential therapeutic targetJournal of Cellular Biochemistry, 2013
- Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platformBiomaterials, 2011
- The brain tumor microenvironmentGlia, 2011
- TGFBIp/βig-h3 protein: A versatile matrix molecule induced by TGF-βThe International Journal of Biochemistry & Cell Biology, 2007
- S100A8 and S100A9 in inflammation and cancerBiochemical Pharmacology, 2006